Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 153

1.

The allogeneic graft-versus-cancer effect.

Ringdén O, Karlsson H, Olsson R, Omazic B, Uhlin M.

Br J Haematol. 2009 Dec;147(5):614-33. doi: 10.1111/j.1365-2141.2009.07886.x. Epub 2009 Sep 4. Review.

PMID:
19735262
4.

Expanded donor natural killer cell and IL-2, IL-15 treatment efficacy in allogeneic hematopoietic stem cell transplantation.

Chen G, Wu D, Wang Y, Cen J, Feng Y, Sun A, Tang X, Chang H, Zhu Z.

Eur J Haematol. 2008 Sep;81(3):226-35. doi: 10.1111/j.1600-0609.2008.01108.x. Epub 2008 Jun 28.

PMID:
18573173
6.

T-cell clones can be rendered specific for CD19: toward the selective augmentation of the graft-versus-B-lineage leukemia effect.

Cooper LJ, Topp MS, Serrano LM, Gonzalez S, Chang WC, Naranjo A, Wright C, Popplewell L, Raubitschek A, Forman SJ, Jensen MC.

Blood. 2003 Feb 15;101(4):1637-44. Epub 2002 Oct 10.

7.

Possible involvement of allogeneic antigens recognised by donor-derived CD4 cytotoxic T cells in selective GVL effects after stem cell transplantation of patients with haematological malignancy.

Matsushita M, Yamazaki R, Ikeda H, Mori T, Sumimoto H, Fujita T, Okamoto S, Ikeda Y, Kawakami Y.

Br J Haematol. 2006 Jan;132(1):56-65.

PMID:
16371020
8.

Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.

Talmadge JE.

Int Immunopharmacol. 2003 Aug;3(8):1121-43. Review.

PMID:
12860168
10.

Graft-versus-leukemia reactions in allogeneic chimeras.

Kolb HJ, Schmid C, Barrett AJ, Schendel DJ.

Blood. 2004 Feb 1;103(3):767-76. Epub 2003 Sep 4. Review.

12.

Graft-vs.-lymphoma effect in various histologies of non-Hodgkin's lymphoma.

Maloney DG.

Leuk Lymphoma. 2003;44 Suppl 3:S99-105. Review.

PMID:
15202532
13.
16.

Experimental and clinical approaches for optimization of the graft-versus-leukemia effect.

Sprangers B, Van Wijmeersch B, Fevery S, Waer M, Billiau AD.

Nat Clin Pract Oncol. 2007 Jul;4(7):404-14. Review.

PMID:
17597705
17.

Engineering hematopoietic grafts: purified allogeneic hematopoietic stem cells plus expanded CD8+ NK-T cells in the treatment of lymphoma.

Verneris MR, Ito M, Baker J, Arshi A, Negrin RS, Shizuru JA.

Biol Blood Marrow Transplant. 2001;7(10):532-42.

19.

Effector memory CD4+ T cells mediate graft-versus-leukemia without inducing graft-versus-host disease.

Zheng H, Matte-Martone C, Li H, Anderson BE, Venketesan S, Sheng Tan H, Jain D, McNiff J, Shlomchik WD.

Blood. 2008 Feb 15;111(4):2476-84. Epub 2007 Nov 28.

20.

Immunotherapy by allogeneic stem cell transplantation.

Ringdén O.

Adv Cancer Res. 2007;97:25-60. Review.

PMID:
17419940

Supplemental Content

Support Center